Indefinite Delivery Contract SPE2DR25D7910

The Indefinite Delivery Contract (IDC) SPE2DR25D7910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2026 and is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and the U.S. Naval Fleet.

The contract encompasses a broad range of pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The IDC serves as a primary vehicle for efficiently procuring these essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract was awarded on a single-award basis without any set-aside requirements, indicating open competition. This contract is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which aims to establish multiple regional prime vendor contracts to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.